S&P 500   3,970.90 (+1.78%)
DOW   31,900.27 (+2.04%)
QQQ   292.20 (+1.22%)
AAPL   142.33 (+3.45%)
MSFT   259.79 (+2.86%)
FB   194.74 (+0.62%)
GOOGL   2,224.58 (+2.13%)
AMZN   2,115.88 (-1.67%)
TSLA   668.89 (+0.75%)
NVDA   167.00 (+0.04%)
BABA   86.65 (-0.16%)
NIO   15.71 (-4.44%)
AMD   94.10 (+0.64%)
CGC   5.15 (-6.70%)
MU   69.37 (+0.68%)
T   20.85 (+2.21%)
GE   75.97 (+0.96%)
F   12.83 (+2.64%)
DIS   104.91 (+2.43%)
AMC   11.59 (-3.66%)
PFE   53.04 (+1.09%)
PYPL   81.10 (+0.70%)
NFLX   185.17 (-0.63%)
S&P 500   3,970.90 (+1.78%)
DOW   31,900.27 (+2.04%)
QQQ   292.20 (+1.22%)
AAPL   142.33 (+3.45%)
MSFT   259.79 (+2.86%)
FB   194.74 (+0.62%)
GOOGL   2,224.58 (+2.13%)
AMZN   2,115.88 (-1.67%)
TSLA   668.89 (+0.75%)
NVDA   167.00 (+0.04%)
BABA   86.65 (-0.16%)
NIO   15.71 (-4.44%)
AMD   94.10 (+0.64%)
CGC   5.15 (-6.70%)
MU   69.37 (+0.68%)
T   20.85 (+2.21%)
GE   75.97 (+0.96%)
F   12.83 (+2.64%)
DIS   104.91 (+2.43%)
AMC   11.59 (-3.66%)
PFE   53.04 (+1.09%)
PYPL   81.10 (+0.70%)
NFLX   185.17 (-0.63%)
S&P 500   3,970.90 (+1.78%)
DOW   31,900.27 (+2.04%)
QQQ   292.20 (+1.22%)
AAPL   142.33 (+3.45%)
MSFT   259.79 (+2.86%)
FB   194.74 (+0.62%)
GOOGL   2,224.58 (+2.13%)
AMZN   2,115.88 (-1.67%)
TSLA   668.89 (+0.75%)
NVDA   167.00 (+0.04%)
BABA   86.65 (-0.16%)
NIO   15.71 (-4.44%)
AMD   94.10 (+0.64%)
CGC   5.15 (-6.70%)
MU   69.37 (+0.68%)
T   20.85 (+2.21%)
GE   75.97 (+0.96%)
F   12.83 (+2.64%)
DIS   104.91 (+2.43%)
AMC   11.59 (-3.66%)
PFE   53.04 (+1.09%)
PYPL   81.10 (+0.70%)
NFLX   185.17 (-0.63%)
S&P 500   3,970.90 (+1.78%)
DOW   31,900.27 (+2.04%)
QQQ   292.20 (+1.22%)
AAPL   142.33 (+3.45%)
MSFT   259.79 (+2.86%)
FB   194.74 (+0.62%)
GOOGL   2,224.58 (+2.13%)
AMZN   2,115.88 (-1.67%)
TSLA   668.89 (+0.75%)
NVDA   167.00 (+0.04%)
BABA   86.65 (-0.16%)
NIO   15.71 (-4.44%)
AMD   94.10 (+0.64%)
CGC   5.15 (-6.70%)
MU   69.37 (+0.68%)
T   20.85 (+2.21%)
GE   75.97 (+0.96%)
F   12.83 (+2.64%)
DIS   104.91 (+2.43%)
AMC   11.59 (-3.66%)
PFE   53.04 (+1.09%)
PYPL   81.10 (+0.70%)
NFLX   185.17 (-0.63%)
ASX:IIQ

INOVIQ (IIQ) Stock Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Receive IIQ News and Ratings via Email

Sign-up to receive the latest news and ratings for INOVIQ and its competitors with MarketBeat's FREE daily newsletter.

About INOVIQ

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic products for the early detection of cancer to enhance patient outcomes in Australia. The company offers hTERT test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for ovarian and breast cancers, and research-stage projects for prostate and other cancers. INOVIQ Ltd has a collaboration with The University of Queensland to develop a exosome-based ovarian cancer screening test. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was incorporated in 1983 and is headquartered in Notting Hill, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
$1.19 million
Book Value
A$0.48 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.33 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -













INOVIQ (ASX:IIQ) Frequently Asked Questions

Who are INOVIQ's key executives?
INOVIQ's management team includes the following people:
  • Dr. Leearne Maree Hinch B.Sc., B.V.M.S., BSc., M.B.A., M.R.C.V.S., Chief Exec. Officer
  • Mr. Tony Di Pietro AGIA, B.Com, C.A., CPA, M.A.I.C.D., CFO & Company Sec.
  • Mr. Peter Lynton Gunzburg ASIA, B Comm, B.Com., Managing Director (Age 70, Pay $6.84k)
  • Prof. Gregory Edward Rice BSc (Hons), GradDipMgt, MHA, Ph.D., Chief Scientific Officer
What is INOVIQ's stock symbol?

INOVIQ trades on the ASX under the ticker symbol "IIQ."

How much money does INOVIQ make?

INOVIQ has a market capitalization of $0.00 and generates $1.19 million in revenue each year.

How many employees does INOVIQ have?

INOVIQ employs 15 workers across the globe.

What is INOVIQ's official website?

The official website for INOVIQ is www.inoviq.com.

How can I contact INOVIQ?

The company can be reached via phone at 61 3 9548 7586.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.